Oral Vaccination withSalmonella entericaas a Cruzipain-DNA Delivery System Confers Protective Immunity againstTrypanosoma cruzi
- 1 January 2008
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (1) , 324-333
- https://doi.org/10.1128/iai.01163-07
Abstract
To stimulate both local and systemic immune responses againstTrypanosoma cruzi,Salmonella entericaserovar TyphimuriumaroAwas exploited as a DNA delivery system for cruzipain (SCz). In a murine model we compared SCz alone (GI) or coadministered withSalmonellacarrying a plasmid encoding granulocyte-macrophage colony-stimulating factor (GII), as well as protocols in which SCz priming was followed by boosting with recombinant cruzipain (rCz) admixed with either CpG-ODN (GIII) or MALP-2, a synthetic derivative of a macrophage-activating lipopeptide of 2 kDa fromMycoplasma fermentans(GIV). The results showed that protocols that included four oral doses of SCz (GI) elicited mainly a mucosal response characterized by immunoglobulin A (IgA) secretion and proliferation of gut-associated lymphoid tissue cells, with weak systemic responses. In contrast, the protocol that included a boost with rCz plus CpG (GIII) triggered stronger systemic responses in terms of Cz-specific serum IgG titers, splenocyte proliferation, gamma interferon (IFN-γ) secretion, and delayed-type hypersensitivity response. Trypomastigote challenge of vaccinated mice resulted in significantly lower levels of parasitemia compared to controls. Protection was abolished by depletion of either CD4+or CD8+T cells. Parasite control was also evident from the reduction of tissue damage, as revealed by histopathologic studies and serum levels of enzymes that are markers of muscle injury in chronic Chagas' disease (i.e., creatine kinase, aspartate aminotransferase, and lactate dehydrogenase). Enhanced release of IFN-γ and interleukin-2 was observed in GI and GII upon restimulation of splenocytes in the nonparasitic phase of infection. Our results indicate thatSalmonella-mediated delivery of Cz-DNA by itself promotes the elicitation of an immune response that controlsT. cruziinfection, thereby reducing parasite loads and subsequent damage to muscle tissues.Keywords
This publication has 60 references indexed in Scilit:
- Contribution of NK, NK T, γδ T, and αβ T Cells to the Gamma Interferon Response Required for Liver Protection againstTrypanosoma cruziInfection and Immunity, 2006
- Delivery of the Immunosuppressive Antigen Salp15 to Antigen-Presenting Cells bySalmonella entericaSerovar TyphimuriumaroAMutantsInfection and Immunity, 2004
- Frequency of Interferon‐γ–Producing T Cells Specific forTrypanosoma cruziInversely Correlates with Disease Severity in Chronic Human Chagas DiseaseThe Journal of Infectious Diseases, 2004
- Contribution of Plasmid DNA to Hepatotoxicity after Systemic Administration of LipoplexesHuman Gene Therapy, 2001
- The Targets of the Lytic Antibody Response against Trypanosoma cruziParasitology Today, 2000
- Chagas Disease Etiology: Autoimmunity or Parasite Persistence?Parasitology Today, 1999
- In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart diseaseAmerican Heart Journal, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruziFEMS Microbiology Letters, 1990
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981